Cash flow Nippon Steel Corporation

Equities

5401

JP3381000003

Iron & Steel

Market Closed - Japan Exchange Other stock markets 01:30:00 2026-01-13 EST			5-day change	1st Jan Change
659.50 ^JPY	+2.15%		+1.35%	+2.76%

01-06	India's competition watchdog approves acquisition of Krosaki Harima Corp by Nippon Steel	RE
12-26	Japan Steel Group Doubts China Export License Will Lift Prices	MT

c.oFSC2Wyu8XTetvE24v_McaudrTGNYn6yrx99RJ02gns.zhLwjQvirkyrjoN9s6WPI-7x_H7UDArIxlVFANQbzC_XP_qLOceiWZH-hg

Published financial data: NIPPON STEEL CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	4,829B	6,809B	7,976B	8,868B	8,696B
Total Revenues	4,829B	6,809B	7,976B	8,868B	8,696B
Cost of Goods Sold, Total	4,264B	5,587B	6,682B	7,481B	7,324B
Gross Profit	565B	1,222B	1,294B	1,387B	1,372B
Selling General & Admin Expenses, Total	399B	470B	498B	639B	815B
R&D Expenses	52.67B	54.55B	58.89B	60.67B	-
Depreciation & Amortization - (IS)	17.09B	19.77B	22.99B	30.86B	-
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	-
Other Operating Expenses	4.77B	-26.85B	-46.38B	-20.1B	-14.23B
Other Operating Expenses, Total	474B	518B	533B	710B	801B
Operating Income	91.43B	704B	761B	676B	571B
Interest Expense, Total	-22.3B	-21.77B	-20.92B	-30.5B	-38.2B
Interest And Investment Income	5.36B	1.92B	8.06B	21.54B	35.62B
Net Interest Expenses	-16.94B	-19.85B	-12.86B	-8.96B	-2.57B
Income (Loss) On Equity Invest.	55.22B	214B	103B	144B	127B
Currency Exchange Gains (Loss)	-3.04B	21.04B	40.02B	50.84B	7.04B
Other Non Operating Income (Expenses)	-3.1B	-4.47B	-3.94B	-5.73B	-6.17B
EBT, Excl. Unusual Items	124B	915B	887B	857B	696B
Restructuring Charges	-98.66B	-97.23B	-32.81B	-91B	-135B
Merger & Related Restructuring Charges	-	-	-	-	-1.08B
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	36.52B	-
Gain (Loss) On Sale Of Assets	-33.56B	20.42B	12.99B	-38.5B	-35.61B
Asset Writedown	-	-21.5B	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-8.66B	817B	867B	764B	524B
Income Tax Expense	10.67B	149B	128B	176B	141B
Earnings From Continuing Operations	-19.33B	668B	739B	588B	383B
Net Income to Company	-19.33B	668B	739B	588B	383B
Minority Interest	-13.1B	-30.21B	-44.72B	-38.53B	-32.74B
Net Income - (IS)	-32.43B	637B	694B	549B	350B
Net Income to Common Incl Extra Items	-32.43B	637B	694B	549B	350B
Net Income to Common Excl. Extra Items	-32.43B	637B	694B	549B	350B
Per Share Items
Net EPS - Basic	-7.04	138.43	150.73	119.32	70.18
Basic EPS - Continuing Operations	-7.04	138.43	150.73	119.32	70.18
Basic Weighted Average Shares Outstanding	4.6B	4.6B	4.6B	4.6B	4.99B
Net EPS - Diluted	-7.04	131.5	134.38	105.59	67.03
Diluted EPS - Continuing Operations	-7.04	131.5	134.38	105.59	67.03
Diluted Weighted Average Shares Outstanding	4.6B	4.85B	5.16B	5.2B	5.22B
Normalized Basic EPS	13.93	117.64	110.65	107.96	80.65
Normalized Diluted EPS	13.93	111.75	98.64	95.54	77.03
Dividend Per Share	2	32	36	32	32
Payout Ratio	-	11.57	23.91	27.69	46.28
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	382B	1,034B	1,101B	1,039B	899B
EBITA	91.43B	704B	761B	676B	576B
EBIT	91.43B	704B	761B	676B	571B
Effective Tax Rate - (Ratio)	-123.28	18.25	14.78	23.05	26.97
Total Current Taxes	-	-	-	-	226B
Total Deferred Taxes	-	-	-	-	-84.21B
Normalized Net Income	64.13B	542B	509B	497B	402B
Non-Cash Pension Expense	-50.43B	5.3B	7.63B	10.94B	-
Supplemental Operating Expense Items
Selling and Marketing Expenses	129B	161B	159B	211B	-
Research And Development Expense From Footnotes	65.3B	66.4B	70.5B	72.7B	80.79B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	359B	551B	670B	449B	673B
Short Term Investments	-	-	-	-	23.79B
Total Cash And Short Term Investments	359B	551B	670B	449B	696B
Accounts Receivable, Total	805B	939B	1,062B	1,588B	1,306B
Other Receivables	-	-	-	-	124B
Total Receivables	805B	939B	1,062B	1,588B	1,430B
Inventory	1,349B	1,757B	2,086B	2,277B	2,199B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	159B	268B	252B	247B	223B
Total Current Assets	2,673B	3,515B	4,071B	4,560B	4,549B
Gross Property Plant And Equipment	-	-	-	-	14,215B
Accumulated Depreciation	-	-	-	-	-10,477B
Net Property Plant And Equipment	3,043B	3,131B	3,268B	3,481B	3,738B
Long-term Investments	1,562B	1,757B	1,870B	2,349B	2,055B
Goodwill	46.34B	61.74B	65.06B	70.21B	71.64B
Other Intangibles, Total	95.83B	130B	157B	178B	263B
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	153B	158B	136B	75.89B	135B
Other Long-Term Assets, Total	4M	5M	4M	5M	132B
Total Assets	7,574B	8,752B	9,567B	10,715B	10,942B
Liabilities
Accounts Payable, Total	1,383B	1,527B	1,592B	1,891B	774B
Short-term Borrowings	106B	123B	158B	156B	208B
Current Portion of Long-Term Debt	180B	201B	225B	363B	244B
Current Portion of Leases	22.68B	20.26B	19.86B	22.59B	22.06B
Current Income Taxes Payable	24.26B	110B	51.92B	80.27B	126B
Unearned Revenue Current, Total	-	-	-	-	52.58B
Other Current Liabilities	55.33B	37.9B	46.72B	69.39B	909B
Total Current Liabilities	1,771B	2,019B	2,094B	2,582B	2,335B
Long-Term Debt	2,181B	2,249B	2,230B	2,089B	1,952B
Long-Term Leases	68.79B	60.78B	66.62B	80.91B	81.92B
Pension & Other Post Retirement Benefits	189B	188B	185B	116B	134B
Deferred Tax Liability Non Current	37.38B	39.8B	37.68B	141B	137B
Other Non Current Liabilities	194B	299B	307B	350B	398B
Total Liabilities	4,443B	4,855B	4,921B	5,359B	5,039B
Common Stock, Total	420B	420B	420B	420B	570B
Additional Paid In Capital	393B	394B	399B	399B	578B
Retained Earnings	1,910B	2,515B	3,079B	3,526B	3,820B
Treasury Stock	-58.34B	-57.98B	-58.05B	-58.15B	-58.24B
Comprehensive Income and Other	95.31B	197B	341B	492B	474B
Total Common Equity	2,760B	3,467B	4,181B	4,778B	5,383B
Minority Interest	371B	430B	465B	578B	520B
Total Equity	3,131B	3,897B	4,646B	5,356B	5,903B
Total Liabilities And Equity	7,574B	8,752B	9,567B	10,715B	10,942B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.6B	4.6B	4.6B	4.61B	5.23B
ECS Total Common Shares Outstanding	4.6B	4.6B	4.6B	4.61B	5.23B
Book Value / Share	599.51	752.94	908.12	1.04K	1.03K
Tangible Book Value	2,618B	3,275B	3,959B	4,530B	5,048B
Tangible Book Value Per Share	568.63	711.19	859.79	983.6	966.03
Total Debt	2,559B	2,653B	2,699B	2,712B	2,507B
Net Debt	2,200B	2,102B	2,029B	2,263B	1,811B
Debt Equivalent of Unfunded Proj. Benefit Obligation	79.06B	64.79B	60.81B	-50.54B	-66.27B
Minority Interest, Total (Incl. Fin. Div)	371B	430B	465B	578B	520B
Equity Method Investments, Total	817B	1,079B	1,211B	1,538B	1,600B
Account Code - Inventory Valuation	-	-	-	-	6
Inventories - Raw Materials, Total	585B	749B	894B	934B	879B
Inventories - Work In Process, Total	75.01B	77.98B	83.61B	98.22B	113B
Inventories - Finished Goods, Total	690B	930B	1,108B	1,244B	1,207B
Inventories - Others	-	2M	1M	2M	-
Land - (BS)	-	-	-	-	738B
Buildings, Total	-	-	-	-	3,037B
Machinery, Total	-	-	-	-	9,807B
Full Time Employees	106K	107K	106K	114K	-
Accumulated Allowance for Doubtful Accounts (Supple)	1.72B	1.55B	1.97B	2.32B	3.93B
Order Backlog	430B	521B	633B	544B	-

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-8.66B	817B	867B	764B	350B
Depreciation & Amortization - CF	291B	331B	340B	363B	347B
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	4.93B
Depreciation & Amortization, Total	291B	331B	340B	363B	352B
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	33.74B
(Gain) Loss From Sale Of Asset	-	21.5B	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	135B
(Income) Loss On Equity Investments - (CF)	-55.22B	-214B	-103B	-144B	-127B
Other Operating Activities, Total	17.45B	-36.8B	-141B	-54.8B	39.02B
Change In Accounts Receivable	-26.78B	-116B	-81.8B	50.13B	205B
Change In Inventories	171B	-383B	-310B	68.62B	95.66B
Change In Accounts Payable	-66.32B	211B	58.43B	-53.63B	-105B
Change in Other Net Operating Assets	80.47B	-13.46B	30.77B	17.2B	-
Cash from Operations	403B	616B	661B	1,010B	979B
Capital Expenditure	-460B	-467B	-470B	-466B	-598B
Sale of Property, Plant, and Equipment	21.75B	70.25B	15.48B	12.38B	13.62B
Cash Acquisitions	-8.05B	-53.01B	-735M	-292B	-114B
Divestitures	22B	-2.27B	5.23B	19.67B	-
Investment in Marketable and Equity Securities, Total	33.71B	72.45B	81.72B	13.51B	264B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-616M	-2.09B	-2.25B	-2.57B	-
Other Investing Activities, Total	1.97B	2.71B	3.99B	5.1B	-28.59B
Cash from Investing	-389B	-379B	-367B	-711B	-462B
Short Term Debt Issued, Total	-	11.11B	27.24B	-	44.11B
Long-Term Debt Issued, Total	650B	320B	200B	85.22B	327B
Total Debt Issued	650B	331B	228B	85.22B	371B
Short Term Debt Repaid, Total	-134B	-	-	-326B	-
Long-Term Debt Repaid, Total	-471B	-267B	-228B	-272B	-299B
Total Debt Repaid	-604B	-267B	-228B	-598B	-299B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-30M	-59M	-58M	-73M	-58M
Common Dividends Paid	-	-73.76B	-166B	-152B	-162B
Common & Preferred Stock Dividends Paid	-	-73.76B	-166B	-152B	-162B
Other Financing Activities, Total	6.78B	-51.44B	-31.25B	121B	-223B
Cash from Financing	52.69B	-61.3B	-198B	-544B	-313B
Foreign Exchange Rate Adjustments	3.16B	16.12B	22.32B	22.92B	20.8B
Miscellaneous Cash Flow Adjustments	1M	-1M	-	-	-
Net Change in Cash	70.01B	192B	119B	-222B	224B
Supplemental Items
Cash Interest Paid	21.73B	21.9B	21.58B	30.56B	36.35B
Cash Income Tax Paid (Refund)	26.73B	86.01B	214B	127B	181B
Levered Free Cash Flow	605M	-148B	-87.89B	-61.39B	185B
Unlevered Free Cash Flow	14.54B	-135B	-74.82B	-42.33B	209B
Change In Net Working Capital	-126B	438B	420B	362B	-64.93B
Net Debt Issued / Repaid	45.94B	63.96B	-396M	-512B	71.8B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	0.76	5.39	5.19	4.17	3.3
Return on Total Capital	1.02	7.19	6.84	5.49	4.33
Return On Equity %	-0.63	19	17.29	11.76	6.8
Return on Common Equity	-1.2	20.47	18.15	12.26	6.89
Margin Analysis
Gross Profit Margin %	11.71	17.94	16.22	15.64	15.77
SG&A Margin	8.27	6.91	6.24	7.2	9.37
EBITDA Margin %	7.92	15.19	13.8	11.72	10.34
EBITA Margin %	1.89	10.33	9.54	7.63	6.62
EBIT Margin %	1.89	10.33	9.54	7.63	6.57
Income From Continuing Operations Margin %	-0.4	9.8	9.26	6.63	4.4
Net Income Margin %	-0.67	9.36	8.7	6.19	4.03
Net Avail. For Common Margin %	-0.67	9.36	8.7	6.19	4.03
Normalized Net Income Margin	1.33	7.95	6.39	5.6	4.63
Levered Free Cash Flow Margin	0.01	-2.18	-1.1	-0.69	2.13
Unlevered Free Cash Flow Margin	0.3	-1.98	-0.94	-0.48	2.41
Asset Turnover
Asset Turnover	0.64	0.83	0.87	0.87	0.8
Fixed Assets Turnover	1.62	2.21	2.49	2.63	2.41
Receivables Turnover (Average Receivables)	5.92	7.81	7.97	6.69	6.26
Inventory Turnover (Average Inventory)	2.96	3.6	3.48	3.43	3.27
Short Term Liquidity
Current Ratio	1.51	1.74	1.94	1.77	1.95
Quick Ratio	0.66	0.74	0.83	0.79	0.91
Operating Cash Flow to Current Liabilities	0.23	0.3	0.32	0.39	0.42
Days Sales Outstanding (Average Receivables)	61.67	46.76	45.81	54.69	58.27
Days Outstanding Inventory (Average Inventory)	123.33	101.45	104.95	106.71	111.53
Average Days Payable Outstanding	126.67	88.58	81.18	83.08	41.4
Cash Conversion Cycle (Average Days)	58.34	59.64	69.57	78.33	128.4
Long Term Solvency
Total Debt/Equity	81.73	68.09	58.1	50.63	42.48
Total Debt / Total Capital	44.97	40.51	36.75	33.61	29.81
LT Debt/Equity	71.86	59.26	49.42	40.52	34.46
Long-Term Debt / Total Capital	39.54	35.25	31.26	26.9	24.18
Total Liabilities / Total Assets	58.66	55.47	51.43	50.01	46.05
EBIT / Interest Expense	4.1	32.32	36.35	22.18	14.95
EBITDA / Interest Expense	17.14	47.5	52.6	34.08	24.16
(EBITDA - Capex) / Interest Expense	-3.48	26.06	30.14	18.79	8.5
Total Debt / EBITDA	6.69	2.57	2.45	2.61	2.72
Net Debt / EBITDA	5.75	2.03	1.84	2.18	1.96
Total Debt / (EBITDA - Capex)	-33.01	4.68	4.28	4.73	7.72
Net Debt / (EBITDA - Capex)	-28.38	3.71	3.22	3.95	5.58
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-18.45	40.99	17.13	11.19	-1.95
Gross Profit, 1 Yr. Growth %	-7.19	116.08	5.89	7.21	-1.09
EBITDA, 1 Yr. Growth %	-17.03	170.55	6.42	-5.56	-7.6
EBITA, 1 Yr. Growth %	110.7	669.68	8.08	-11.05	-13.54
EBIT, 1 Yr. Growth %	110.7	669.68	8.08	-11.05	-13.62
Earnings From Cont. Operations, 1 Yr. Growth %	-95.46	-3.55K	10.67	-20.42	-34.86
Net Income, 1 Yr. Growth %	-92.48	-2.07K	8.9	-20.84	-36.25
Normalized Net Income, 1 Yr. Growth %	87.18	744.59	-5.94	-2.43	-19.03
Diluted EPS Before Extra, 1 Yr. Growth %	-92.49	-1.97K	2.19	-21.42	-36.52
Accounts Receivable, 1 Yr. Growth %	-2.58	16.65	13.09	49.47	-11.17
Inventory, 1 Yr. Growth %	-11.93	30.18	18.75	9.14	-3.41
Net Property, Plant and Equip., 1 Yr. Growth %	4.72	2.87	4.37	6.53	7.37
Total Assets, 1 Yr. Growth %	1.73	15.56	9.31	11.99	2.13
Tangible Book Value, 1 Yr. Growth %	4.74	25.09	20.89	14.42	11.45
Common Equity, 1 Yr. Growth %	4.48	25.61	20.61	14.27	12.68
Cash From Operations, 1 Yr. Growth %	-18.44	52.69	7.41	52.76	-3.12
Capital Expenditures, 1 Yr. Growth %	-0.16	1.54	0.67	-0.78	28.22
Levered Free Cash Flow, 1 Yr. Growth %	-106.77	-24.6K	-40.71	-30.16	-437.4
Unlevered Free Cash Flow, 1 Yr. Growth %	210.05	-1.03K	-44.43	-43.43	-683.31
Dividend Per Share, 1 Yr. Growth %	0	1.5K	12.5	-11.11	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-11.59	7.23	28.51	14.12	4.42
Gross Profit, 2 Yr. CAGR %	-15.22	41.61	51.27	6.55	2.97
EBITDA, 2 Yr. CAGR %	-22.42	49.83	69.68	0.25	-11.74
EBITA, 2 Yr. CAGR %	-39.26	302.7	188.42	-1.95	-15.85
EBIT, 2 Yr. CAGR %	-38.84	302.7	188.42	-1.95	-16.21
Earnings From Cont. Operations, 2 Yr. CAGR %	-72.61	25.16	518.25	-6.15	-28
Net Income, 2 Yr. CAGR %	-64.07	21.53	362.59	-7.16	-28.96
Normalized Net Income, 2 Yr. CAGR %	-44.28	297.61	181.86	-4.2	-11.82
Diluted EPS Before Extra, 2 Yr. CAGR %	-64.64	18.43	336.75	-10.39	-29.37
Accounts Receivable, 2 Yr. CAGR %	-2.1	6.61	14.86	30.02	10.88
Inventory, 2 Yr. CAGR %	-7.21	7.07	24.33	13.85	2.68
Net Property, Plant and Equip., 2 Yr. CAGR %	-3.18	3.79	3.62	5.45	6.95
Total Assets, 2 Yr. CAGR %	-3	8.43	12.39	10.64	6.95
Tangible Book Value, 2 Yr. CAGR %	-7.69	14.46	22.97	17.61	12.93
Common Equity, 2 Yr. CAGR %	-7.57	14.56	23.08	17.39	13.47
Cash From Operations, 2 Yr. CAGR %	-5.59	11.6	28.07	28.1	21.65
Capital Expenditures, 2 Yr. CAGR %	2.37	0.69	1.1	-0.06	12.79
Levered Free Cash Flow, 2 Yr. CAGR %	-93.93	307.21	1.11K	-35.65	79.94
Unlevered Free Cash Flow, 2 Yr. CAGR %	-69.12	435.81	126.83	-43.93	124.02
Dividend Per Share, 2 Yr. CAGR %	-64.64	300	324.26	0	-5.72
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-5.45	3.29	10.44	22.46	8.49
Gross Profit, 3 Yr. CAGR %	-9.55	15.81	28.53	34.87	3.94
EBITDA, 3 Yr. CAGR %	-14.23	17.65	33.68	39.58	-5.18
EBITA, 3 Yr. CAGR %	-29.54	41.61	159.76	94.86	-7.32
EBIT, 3 Yr. CAGR %	-29.22	42.26	159.76	94.86	-7.59
Earnings From Cont. Operations, 3 Yr. CAGR %	-55.01	37.36	20.13	212.16	-16.91
Net Income, 3 Yr. CAGR %	-43.61	36.39	17.16	156.82	-18.09
Normalized Net Income, 3 Yr. CAGR %	-27.58	37.89	145.91	97.91	-9.39
Diluted EPS Before Extra, 3 Yr. CAGR %	-44.4	32.64	12.75	146.56	-20.12
Accounts Receivable, 3 Yr. CAGR %	3.39	3.79	8.72	25.4	11.61
Inventory, 3 Yr. CAGR %	-1.22	3.88	10.83	19.05	7.78
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.86	-1.2	3.98	4.58	6.08
Total Assets, 3 Yr. CAGR %	-0.79	2.83	8.72	12.26	7.73
Tangible Book Value, 3 Yr. CAGR %	-4.42	2.15	16.56	20.05	15.52
Common Equity, 3 Yr. CAGR %	-4.18	2.38	16.54	20.07	15.8
Cash From Operations, 3 Yr. CAGR %	-6.01	10.82	10.18	35.82	16.71
Capital Expenditures, 3 Yr. CAGR %	3.73	2.09	0.68	0.47	8.6
Levered Free Cash Flow, 3 Yr. CAGR %	-77.88	-3.39	114.22	366.42	-
Unlevered Free Cash Flow, 3 Yr. CAGR %	-40.56	-4.06	151.73	42.78	-
Dividend Per Share, 3 Yr. CAGR %	-47.72	25.99	162.07	151.98	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.32	7.71	6.9	7.5	-
Gross Profit, 5 Yr. CAGR %	-1.8	14.85	11.1	12.01	-
EBITDA, 5 Yr. CAGR %	-4.43	16.44	12.68	10.35	-
EBITA, 5 Yr. CAGR %	-11.79	35.8	23.82	22.25	-
EBIT, 5 Yr. CAGR %	-11.43	35.8	24.16	22.58	-
Earnings From Cont. Operations, 5 Yr. CAGR %	-33.76	34	28.33	17.94	-
Net Income, 5 Yr. CAGR %	-25.93	35.95	30.86	16.94	-
Normalized Net Income, 5 Yr. CAGR %	-12.96	40.31	24.71	19.2	-
Diluted EPS Before Extra, 5 Yr. CAGR %	-26	33.49	26.81	13.38	-
Accounts Receivable, 5 Yr. CAGR %	9.03	8.6	7.83	13.58	-
Inventory, 5 Yr. CAGR %	3.97	7.64	8.3	7.76	-
Net Property, Plant and Equip., 5 Yr. CAGR %	3.37	1.96	0.9	1.4	-
Total Assets, 5 Yr. CAGR %	3.34	3.8	4.29	5.89	-
Tangible Book Value, 5 Yr. CAGR %	-0.51	2.77	5.72	8.08	-
Common Equity, 5 Yr. CAGR %	-0.1	3.29	5.91	8.14	-
Cash From Operations, 5 Yr. CAGR %	-6.46	3.96	6.37	17.43	-
Capital Expenditures, 5 Yr. CAGR %	9.01	7.25	2.67	1.23	-
Levered Free Cash Flow, 5 Yr. CAGR %	-71.09	-0.46	9.47	-17.88	-
Unlevered Free Cash Flow, 5 Yr. CAGR %	-45.85	-3.84	1.56	-22.61	-
Dividend Per Share, 5 Yr. CAGR %	-25.98	28.88	20.79	14.87	-